Rephonic
Artwork for Out of the Lab: Operationalizing Cell and Gene Therapy

Out of the Lab: Operationalizing Cell and Gene Therapy

Nicholas (Nico) Crudele
Cell Therapy
Cell and Gene Therapy
Tech Transfer
GMP
Documentation
Gene Therapy
Car-T Therapies
Clinical Trials
Car T Therapies
Aphoresis
Cryopreservation
CDMO
Decentralization
Rural Healthcare Access
National Cancer Institute
FDA
CAR T Therapy
Accreditations
Biopharmaceutical Supply Chain
Lean Manufacturing

tech transfer, process control, travel requirements, audits These silent operational breakdowns prevent life-saving cell and gene therapy treatments from ever reaching patients, and kill IP-backed companies. This show is for executives on the path to clinic, de-risking their clinical assets. Leverage insights hard-earned from countless years in the industry, ranging from the manufacturing floor th... more

PublishesWeeklyEpisodes34Founded10 months ago
Number of ListenersCategories
BusinessEntrepreneurship

Listen to this Podcast

Artwork for Out of the Lab: Operationalizing Cell and Gene Therapy

Latest Episodes

What happens when the biopharmaceutical industry tries to force living, hyper-perishable cell therapies into a legacy supply chain built for shelf-stable small molecules?

The entire system breaks down.

In this episode of Out of the Lab, host Nico s... more

YouTube

What happens when a life-saving gene therapy is developed for a patient population of only 30 people? The traditional pharmaceutical business model completely breaks down.

In this episode of Out of the Lab, host Nico sits down with Craig Martin, CEO... more

YouTube

"Cell and gene therapy developers are contending with the same problems the early pioneers of lean production contended with. Specifically, a frugal environment with scarce resources."

— Andrew, ScaleReady.

In this episode of Out of the Lab, we s... more

YouTube

How do you scale a supply chain when an entire manufacturing run is for one patient, and the starting material is inside them?

In this episode of Out of the Lab, we dive deep into the messy, complex, and high-stakes world of cell and gene therapy (C... more

YouTube

In this episode of Out of the Lab, we tackle the intersection of cutting-edge technology and strict biopharma regulation. We are joined by Jose Caraballo-Oramas (Founder & Principal Advisor, JCO Global Advisory LLC, former Vice President of Global Co... more

YouTube

In this episode of the Out of the Lab Podcast, we sit down with Dr. Rishi Chavan from the Children's Hospital of Orange County. As a pediatric oncologist specializing in stem cell transplants, Dr. Chavan provides a unique perspective on bridging the ... more

YouTube

What happens after a patient survives a groundbreaking clinical trial?

In this episode of Out of the Lab, host Nicholas Crudele sits down with Betsy Larrabee, a parent and patient advocate, to discuss the realities of pediatric CAR T-cell therapy. W... more

YouTube

In this episode of Out of the Lab, host Nico Crudele is joined by Adrienne Mendoza from BBG to unpack the massive operational challenges holding back patient access in cell and gene therapy.

We discuss why the physical science isn't the primary bott... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The Ezra Klein Show
The Ezra Klein ShowNew York Times Opinion

Recent Guests

Craig Martin
CEO of the Orphan Therapeutics Accelerator
Orphan Therapeutics Accelerator
Episode: Fixing the Broken Business Model of Rare Disease Gene Therapies | Craig Martin
Tatyana Matveeva
Director of CGMP Operations at Harvard and Mass General
Harvard/Mass General
Episode: Beyond Backups: Redefining Logistics in Advanced Therapies & Biologics
Jose Caraballo-Oramas
Quality expert with a comprehensive view of the quality space for cell and gene therapy
Episode: You Can’t Delegate Accountability to AI: Jose Caraballo-Oramas
Dr. Rishi Chavan
Pediatric oncologist by training focused on stem cell transplant for kids and young adults
Children's Hospital of Orange County
Episode: Anticipating Failure: How Good Documentation Acts as a Time Machine with Dr. Rishi Chavan
Betsy Larrabee
Patient-parent advocate focused on post-treatment care and access equity
Independent advocate
Episode: The Hidden Costs of Cell Therapy: Post-Treatment Care Gaps with Patient-Parent Advocate Betsy Larrabee
Melinda Bachini
Advocate for cell and gene therapies
Episode: Surviving Stage 4 Cancer: Melinda Bachini on Cell Therapy Patient Access & Barriers
Paul Chun
Episode: Laying the Rails for Advanced Therapies: Paul Chun on Cell & Gene Operations
François-Xavier Lacasse
Professor, expert in tech transfer and pharmaceutical development
Episode: You Don't Know What You Don't Know: The Hidden Traps in Tech Transfer with François-Xavier Lacasse

Hosts

Nico
Host of Out of the Lab: Operationalizing Cell and Gene Therapy
Nicholas
Host of the show, guiding the interview

Top Entrepreneurship Podcasts

Proven Podcast
Proven PodcastCharles Schwartz
Young and Profiting with Hala Taha (Entrepreneurship, Sales, Marketing)
Young and Profiting with Hala Taha (Entrepreneurship, Sales, Marketing)Hala Taha | Entrepreneurship, Sales, Marketing | YAP Media Network
The Money Mondays
The Money MondaysDan Fleyshman
The Prof G Pod with Scott Galloway
The Prof G Pod with Scott GallowayVox Media Podcast Network

Talking Points

Recent interactions between the hosts and their guests.

The Cost of Waiting: Why Speed to Patient is the Ultimate Metric
Q: From your first-person perspective, what are the current challenges or friction points in accessibility and value for patients?
The key challenge is that focusing on cost of goods obscures the real value to patients. We must measure what patients receive in terms of quality of life and meaningful outcomes, not just the price of manufacturing. Faster, safer delivery and better understanding of what goes into the product are essential to ensure treatments reach patients who need them most.
Decentralizing the Cure: The Road to Community-Based CAR-T
Q: How feasible is decentralized manufacturing versus focusing on community-based logistics like aphoresis and cryopreservation?
Decentralized manufacturing is a longer-term goal; the near-term feasibility lies in solidifying aphoresis access, cryopreservation near patients, and last-mile infusion support—then evaluating decentralized manufacturing once validated, digitized, and financially workable; manufacturing decentralization should come after these operational foundations.
The Hidden Costs of Cell Therapy: Post-Treatment Care Gaps with Patient-Parent Advocate Betsy Larrabee
Q: What would ideal post-care look like moving forward?
A dedicated, multi-disciplinary care team for the post-therapy phase, trial designs that incorporate long-term follow-up, and scalable access solutions so families don't have to relocate or deplete savings to get necessary care.
The Hidden Costs of Cell Therapy: Post-Treatment Care Gaps with Patient-Parent Advocate Betsy Larrabee
Q: What happens after CAR T therapy?
Post-treatment care often extends well beyond the initial therapy, with ongoing monitoring, immune suppression concerns, and a lack of standardized, accessible long-term care plans across centers, which creates a sense of a 'frontier' with little guidance.
The Fatal Cost of Paper Records in Cell Therapy | Out of the Lab with Adrienne Mendoza
Q: What do you see as the current biggest barriers in cell and gene therapy, and what is preventing it from getting into the hands of patients today?
The major hurdle is not the science or the manufacturing, but translating breakthroughs into a scalable, community-accessible process. Centralized sites create access gaps, especially in large regions, and the economics of stand-up for rare indications deter broader rollout.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This show focuses on the operational side of cell and gene therapies, with guests and hosts unpacking real-world challenges in tech transfer, manufacturing, quality systems, supply chains, and patient access. Episodes frequently center on cost structures, lean manufacturing, decentralized delivery, data sharing, and regulatory alignment, all through practical, outcomes-driven conversations aimed at de-risking assets heading toward clinic. A notable strength is the emphasis on actionable insights—such as how to speed patient access, streamline documentation, and design scalable transfer strategies—delivered by practitioners who have led or transformed manufacturing and distribution in CGT environments. The format tends to mix case-based narr... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. The Ezra Klein Show

How many episodes of this podcast are there?

this podcast launched 10 months ago and published 34 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Craig Martin
2. Tatyana Matveeva
3. Jose Caraballo-Oramas
4. Dr. Rishi Chavan
5. Betsy Larrabee
6. Melinda Bachini
7. Paul Chun
8. François-Xavier Lacasse

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days